260 related articles for article (PubMed ID: 29515123)
21. Mucosal-associated invariant T cell receptor recognition of small molecules presented by MR1.
Awad W; Le Nours J; Kjer-Nielsen L; McCluskey J; Rossjohn J
Immunol Cell Biol; 2018 Jul; 96(6):588-597. PubMed ID: 29393543
[TBL] [Abstract][Full Text] [Related]
22. Type I interferons are important co-stimulatory signals during T cell receptor mediated human MAIT cell activation.
Lamichhane R; Galvin H; Hannaway RF; de la Harpe SM; Munro F; Tyndall JD; Vernall AJ; McCall JL; Husain M; Ussher JE
Eur J Immunol; 2020 Feb; 50(2):178-191. PubMed ID: 31608441
[TBL] [Abstract][Full Text] [Related]
23. Steroid-induced Deficiency of Mucosal-associated Invariant T Cells in the Chronic Obstructive Pulmonary Disease Lung. Implications for Nontypeable Haemophilus influenzae Infection.
Hinks TS; Wallington JC; Williams AP; Djukanović R; Staples KJ; Wilkinson TM
Am J Respir Crit Care Med; 2016 Nov; 194(10):1208-1218. PubMed ID: 27115408
[TBL] [Abstract][Full Text] [Related]
24. Antibody opsonization enhances MAIT cell responsiveness to bacteria via a TNF-dependent mechanism.
Bánki Z; Krabbendam L; Klaver D; Leng T; Kruis S; Mehta H; Müllauer B; Orth-Höller D; Stoiber H; Willberg CB; Klenerman P
Immunol Cell Biol; 2019 Jul; 97(6):538-551. PubMed ID: 30695101
[TBL] [Abstract][Full Text] [Related]
25. A Critical Role for Mucosal-Associated Invariant T Cells as Regulators and Therapeutic Targets in Systemic Lupus Erythematosus.
Murayama G; Chiba A; Suzuki H; Nomura A; Mizuno T; Kuga T; Nakamura S; Amano H; Hirose S; Yamaji K; Suzuki Y; Tamura N; Miyake S
Front Immunol; 2019; 10():2681. PubMed ID: 31849932
[TBL] [Abstract][Full Text] [Related]
26. Clinical relevance of circulating mucosal-associated invariant T cell levels and their anti-cancer activity in patients with mucosal-associated cancer.
Won EJ; Ju JK; Cho YN; Jin HM; Park KJ; Kim TJ; Kwon YS; Kee HJ; Kim JC; Kee SJ; Park YW
Oncotarget; 2016 Nov; 7(46):76274-76290. PubMed ID: 27517754
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-18 Is Critical for Mucosa-Associated Invariant T Cell Gamma Interferon Responses to Francisella Species
Jesteadt E; Zhang I; Yu H; Meierovics A; Chua Yankelevich WJ; Cowley S
Infect Immun; 2018 May; 86(5):. PubMed ID: 29507084
[TBL] [Abstract][Full Text] [Related]
28. Mucosal-Associated Invariant T Cells Are More Activated in Chronic Hepatitis B, but Not Depleted in Blood: Reversal by Antiviral Therapy.
Boeijen LL; Montanari NR; de Groen RA; van Oord GW; van der Heide-Mulder M; de Knegt RJ; Boonstra A
J Infect Dis; 2017 Nov; 216(8):969-976. PubMed ID: 28968772
[TBL] [Abstract][Full Text] [Related]
29. Circulating and tumor-infiltrating mucosal associated invariant T (MAIT) cells in colorectal cancer patients.
Ling L; Lin Y; Zheng W; Hong S; Tang X; Zhao P; Li M; Ni J; Li C; Wang L; Jiang Y
Sci Rep; 2016 Feb; 6():20358. PubMed ID: 26837580
[TBL] [Abstract][Full Text] [Related]
30. Generation of antitumor invariant natural killer T cell lines in multiple myeloma and promotion of their functions via lenalidomide: a strategy for immunotherapy.
Song W; van der Vliet HJ; Tai YT; Prabhala R; Wang R; Podar K; Catley L; Shammas MA; Anderson KC; Balk SP; Exley MA; Munshi NC
Clin Cancer Res; 2008 Nov; 14(21):6955-62. PubMed ID: 18980990
[TBL] [Abstract][Full Text] [Related]
31. MAIT cells are reduced in frequency and functionally impaired in human T lymphotropic virus type 1 infection: Potential clinical implications.
Paquin-Proulx D; Greenspun BC; Costa EA; Segurado AC; Kallas EG; Nixon DF; Leal FE
PLoS One; 2017; 12(4):e0175345. PubMed ID: 28384290
[TBL] [Abstract][Full Text] [Related]
32. Leveraging Public Single-Cell and Bulk Transcriptomic Datasets to Delineate MAIT Cell Roles and Phenotypic Characteristics in Human Malignancies.
Yao T; Shooshtari P; Haeryfar SMM
Front Immunol; 2020; 11():1691. PubMed ID: 32849590
[TBL] [Abstract][Full Text] [Related]
33. Revealing the protective and pathogenic potential of MAIT cells.
D'Souza C; Chen Z; Corbett AJ
Mol Immunol; 2018 Nov; 103():46-54. PubMed ID: 30196233
[TBL] [Abstract][Full Text] [Related]
34. Persistent deficiency of circulating mucosal-associated invariant T (MAIT) cells in ANCA-associated vasculitis.
Braudeau C; Amouriaux K; Néel A; Herbreteau G; Salabert N; Rimbert M; Martin JC; Hémont C; Hamidou M; Josien R
J Autoimmun; 2016 Jun; 70():73-9. PubMed ID: 27102145
[TBL] [Abstract][Full Text] [Related]
35. Stabilizing short-lived Schiff base derivatives of 5-aminouracils that activate mucosal-associated invariant T cells.
Mak JY; Xu W; Reid RC; Corbett AJ; Meehan BS; Wang H; Chen Z; Rossjohn J; McCluskey J; Liu L; Fairlie DP
Nat Commun; 2017 Mar; 8():14599. PubMed ID: 28272391
[TBL] [Abstract][Full Text] [Related]
36. MAIT cells accumulate in placental intervillous space and display a highly cytotoxic phenotype upon bacterial stimulation.
Solders M; Gorchs L; Erkers T; Lundell AC; Nava S; Gidlöf S; Tiblad E; Magalhaes I; Kaipe H
Sci Rep; 2017 Jul; 7(1):6123. PubMed ID: 28733576
[TBL] [Abstract][Full Text] [Related]
37. Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin Metabolites.
Sakala IG; Kjer-Nielsen L; Eickhoff CS; Wang X; Blazevic A; Liu L; Fairlie DP; Rossjohn J; McCluskey J; Fremont DH; Hansen TH; Hoft DF
J Immunol; 2015 Jul; 195(2):587-601. PubMed ID: 26063000
[TBL] [Abstract][Full Text] [Related]
38. Mucosal-Associated Invariant T Cells in Autoimmune Diseases.
Chiba A; Murayama G; Miyake S
Front Immunol; 2018; 9():1333. PubMed ID: 29942318
[TBL] [Abstract][Full Text] [Related]
39. Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma.
Görgün G; Samur MK; Cowens KB; Paula S; Bianchi G; Anderson JE; White RE; Singh A; Ohguchi H; Suzuki R; Kikuchi S; Harada T; Hideshima T; Tai YT; Laubach JP; Raje N; Magrangeas F; Minvielle S; Avet-Loiseau H; Munshi NC; Dorfman DM; Richardson PG; Anderson KC
Clin Cancer Res; 2015 Oct; 21(20):4607-18. PubMed ID: 25979485
[TBL] [Abstract][Full Text] [Related]
40. MAIT, MR1, microbes and riboflavin: a paradigm for the co-evolution of invariant TCRs and restricting MHCI-like molecules?
Mondot S; Boudinot P; Lantz O
Immunogenetics; 2016 Aug; 68(8):537-48. PubMed ID: 27393664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
